February 1-2, 2027
|
8 AM - 4 PM Eastern Time, US
First Round Abstract Submission Deadline:November 15, 2026
Professor of Molecular Microbiology and Biochemistry
Institute of Structural and Molecular Biology
UCL and Birkbeck, University of London
Visiting Professor of Infection Biology
Ineos Oxford Institute, University of Oxford
Global Ambassador for the UK (Applied Microbiology International)
Learn from world-renowned researchers, clinicians, and thought leaders who are advancing TB research and shaping a healthier tomorrow.
Weill Cornell Medical College, USA
Talk: Genes On Which Mtb Depends to Infect a New Host
SPEAKER
Research Center Borstel, Leibniz Lung Center, Germany
Talk: New Therapies for TB
SPEAKER
Weill Cornell Medical College, USA
Talk: Metabolic Control of Drug Resistance via a Mycobacterial Ion Channel
SPEAKER
University of Southampton, UK
Talk: Identifying New TB Treatment Approaches Through 3D Cell Culture Modelling
SPEAKER
University of Leicester, UK
Talk: What we need to know about transmission of the tubercle bacillus
SPEAKER
Weill Cornell Medical College, USA
Talk: Genetic Approaches To Facilitate TB Drug Development
SPEAKER
UMass Chan Medical School, USA
Talk: Host and Pathogen Genetic Determinants of TB Outcome
SPEAKER
Institute of Biomedicine of Valencia, Spain
Talk: Genomic Approaches in Mycobacterium tuberculosis: From Biology to Precision TB Control
SPEAKER
London School of Hygiene and Tropical Medicine, UK
Talk: Studies from a Human TB Postmortem Cohort
SPEAKER
University of Cape Town, Institute of Infectious Disease and Molecular Medicine, South Africa
Talk: What causes tuberculosis?
SPEAKER
University of Maryland, USA
Talk: Interaction of Mycobacteria with Host Cell Inflammasomes
SPEAKER
University of Oxford, UK
Talk: Towards New TB Vaccines: Identifying Novel Antigens and Immune Correlates of Protection
SPEAKERAn interactive online conference bringing together researchers, clinicians, and innovators worldwide to exchange ideas, share breakthroughs, and advance the future of tuberculosis and mycobacteriology.
This global gathering will convene leading researchers, clinicians, and innovators to explore transformative advances in tuberculosis (TB) and mycobacterial science covering diverse perspectives from basic science to translational research.
With TB remaining a formidable global health challenge— compounded by the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains—this conference provides a timely and interdisciplinary platform to accelerate scientific discovery and collaborative solutions.
Host–microbe interactions
Immune responses & vaccine innovation
Novel diagnostics & therapeutic strategies
Resistance mechanisms & antibiotic discovery
Genomic surveillance
Therapies & model systems for TB
We welcome submissions from Early Career Researchers (ECRs), defined as final-year PhD students and researchers in the early stages of establishing an independent research profile, typically within eight years of completing a doctoral degree or equivalent training.
This includes late-stage doctoral candidates, postdoctoral researchers and those transitioning to independence. Allowances are made for career breaks and non-linear career paths, with ECR status determined by career stage and opportunity rather than job title or length of service.
Submit Your ProposalThe virtual format ensures a globally accessible, flexible and knowledge-rich conference experience.
Low-cost registration fees with no travel or accommodation expenses.
Join from anywhere with flexible scheduling.
Access pre-publication insights and novel findings.
Engage directly with global experts and peers.
Dedicated sessions for early-career researchers.